These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8547681)

  • 1. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells.
    Hashiyama M; Iwama A; Ohshiro K; Kurozumi K; Yasunaga K; Shimizu Y; Masuho Y; Matsuda I; Yamaguchi N; Suda T
    Blood; 1996 Jan; 87(1):93-101. PubMed ID: 8547681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.
    Batard P; Sansilvestri P; Scheinecker C; Knapp W; Debili N; Vainchenker W; Bühring HJ; Monier MN; Kukk E; Partanen J; Matikainen MT; Alitalo R; Hatzfeld J; Alitalo K
    Blood; 1996 Mar; 87(6):2212-20. PubMed ID: 8630381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
    Rappold I; Ziegler BL; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons PJ; Zannettino AC; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring HJ
    Blood; 1997 Jul; 90(1):111-25. PubMed ID: 9207445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Tie gene expression by leukemia inhibitory factor and steel factor in CD34+ cells from human umbilical cord blood.
    Ge Y; Li ZH; Yung YP; Ratzkin BJ; Broxmeyer HE; Lu L
    J Leukoc Biol; 1997 Oct; 62(4):510-6. PubMed ID: 9335322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells.
    Sato A; Iwama A; Takakura N; Nishio H; Yancopoulos GD; Suda T
    Int Immunol; 1998 Aug; 10(8):1217-27. PubMed ID: 9723709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tie receptor tyrosine kinase in human leukemia cell lines.
    Bredoux C; Uphoff CC; Drexler HG
    Leuk Res; 1997 Jul; 21(7):595-601. PubMed ID: 9301679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells.
    Yano M; Iwama A; Nishio H; Suda J; Takada G; Suda T
    Blood; 1997 Jun; 89(12):4317-26. PubMed ID: 9192754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells.
    Iwama A; Hamaguchi I; Hashiyama M; Murayama Y; Yasunaga K; Suda T
    Biochem Biophys Res Commun; 1993 Aug; 195(1):301-9. PubMed ID: 8395828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells.
    Gunji Y; Nakamura M; Osawa H; Nagayoshi K; Nakauchi H; Miura Y; Yanagisawa M; Suda T
    Blood; 1993 Dec; 82(11):3283-9. PubMed ID: 7694677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
    Carlo-Stella C; Regazzi E; Sammarelli G; Colla S; Garau D; Gazit A; Savoldo B; Cilloni D; Tabilio A; Levitzki A; Rizzoli V
    Blood; 1999 Jun; 93(11):3973-82. PubMed ID: 10339507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver.
    Hsu HC; Ema H; Osawa M; Nakamura Y; Suda T; Nakauchi H
    Blood; 2000 Dec; 96(12):3757-62. PubMed ID: 11090057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors.
    Fennie C; Cheng J; Dowbenko D; Young P; Lasky LA
    Blood; 1995 Dec; 86(12):4454-67. PubMed ID: 8541534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells.
    Kukk E; Wartiovaara U; Gunji Y; Kaukonen J; Bühring HJ; Rappold I; Matikainen MT; Vihko P; Partanen J; Palotie A; Alitalo K; Alitalo R
    Br J Haematol; 1997 Jul; 98(1):195-203. PubMed ID: 9233584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and chromosomal localization of PTPRO, a novel receptor protein tyrosine phosphatase, expressed in hematopoietic stem cells.
    Avraham S; London R; Tulloch GA; Ellis M; Fu Y; Jiang S; White RA; Painter C; Steinberger AA; Avraham H
    Gene; 1997 Dec; 204(1-2):5-16. PubMed ID: 9434160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia inhibitory factor and steel factor regulate tie message stability in CD34+ cells from human umbilical cord blood.
    Ge Y; Broxmeyer HE; Lu L
    In Vivo; 1998; 12(2):149-53. PubMed ID: 9627795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
    Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
    Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia.
    Ghaffari S; Dougherty GJ; Lansdorp PM; Eaves AC; Eaves CJ
    Blood; 1995 Oct; 86(8):2976-85. PubMed ID: 7579390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
    Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.
    Ratajczak MZ; Kuczynski WI; Sokol DL; Moore JS; Pletcher CH; Gewirtz AM
    Blood; 1995 Sep; 86(6):2161-7. PubMed ID: 7545021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.